These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 1084819
1. Respiratory involvement in systemic lupus erythematosus. A clinical and immunological study. Holgate ST, Glass DN, Haslam P, Maini RN, Turner-Warwick M. Clin Exp Immunol; 1976 Jun; 24(3):385-95. PubMed ID: 1084819 [Abstract] [Full Text] [Related]
2. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody. Cameron JS, Lessof MH, Ogg CS, Williams BD, Williams DG. Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678 [Abstract] [Full Text] [Related]
3. The value of tests for antibodies to DNA in monitoring the clinical course of SLE. A long-term study using the Farr test and the DNA counterimmunoelectrophoretic method. Edmonds JP, Johnson GD, Ansell BM, Holborow EJ. Clin Exp Immunol; 1975 Oct; 22(1):9-15. PubMed ID: 1082397 [Abstract] [Full Text] [Related]
4. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Adu D, Williams DG, Taube D, Vilches AR, Turner DR, Cameron JS, Ogg CS. Q J Med; 1983 Oct; 52(208):471-87. PubMed ID: 6606818 [Abstract] [Full Text] [Related]
5. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus. Nguyen CP, Cao VV, Fehér J, Gergely P. Acta Med Hung; 1988 Oct; 45(2):145-59. PubMed ID: 3266790 [Abstract] [Full Text] [Related]
6. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus]. Horák P, Hermanová Z, Faltýnek L, Pospísil Z, Scudla V. Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876 [Abstract] [Full Text] [Related]
7. Anticardiolipin antibodies: association with anti-DNA antibodies, disease activity, renal involvement and a history of thrombosis in systemic lupus erythematosus. Reul R, Kádár J, Bodó I, Gergely P. Acta Med Hung; 1997 Oct; 49(3-4):201-5. PubMed ID: 1345458 [Abstract] [Full Text] [Related]
8. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique]. Massardo L, Martínez ME, Pérez R, Ramírez V, Foradori A, González A, Radrigán F, Gutiérrez F, Jacobelli S. Rev Med Chil; 1999 Apr; 127(4):411-20. PubMed ID: 10451606 [Abstract] [Full Text] [Related]
14. [Elevated C reactive protein rate in 23 black African patients with systemic lupus erythematosus and without opportunistic infectious disease]. Iba-Ba J, Biteghe B, Missounga L, Ibouili RB, Mipinda JB, Coniquet S, Kombila JB, Boguikouma JB. Sante; 2009 Apr; 19(2):67-71. PubMed ID: 20031513 [Abstract] [Full Text] [Related]
15. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus]. Pigrau A, Martínez-Vázquez JM, Bacardí R, Ocanña I, Pahissa A. Med Clin (Barc); 1984 Dec 08; 83(19):787-91. PubMed ID: 6335542 [No Abstract] [Full Text] [Related]
16. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC. Arthritis Res Ther; 2006 Dec 08; 8(6):R162. PubMed ID: 17062137 [Abstract] [Full Text] [Related]
17. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Vilá LM, Alarcón GS, McGwin G, Bastian HM, Fessler BJ, Reveille JD, Lumina Study Group. Arthritis Rheum; 2006 Oct 15; 55(5):799-806. PubMed ID: 17013840 [Abstract] [Full Text] [Related]
18. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Jonsson H, Nived O, Sturfelt G. Medicine (Baltimore); 1989 May 15; 68(3):141-50. PubMed ID: 2785628 [Abstract] [Full Text] [Related]